Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to the UK

The forecasted import values for blood, antisera, vaccines, toxins, and cultures in the UK show a steady upward trajectory from 2024 to 2028, starting at $11.949 billion and reaching $13.229 billion. This indicates a consistent year-on-year growth in the range of approximately 2.7% to 2.8%. The compound annual growth rate (CAGR) over the five-year period is projected at around 2.1%, reflecting gradual yet steady market expansion. As of 2023, actual imports stood at a value slightly lower than the forecasted 2024 figures.

Looking ahead, several trends are poised to influence this sector:

• Innovation in biotechnology that may drive demand for advanced medical products.
• Regulatory changes that could impact import dynamics.
• Global health initiatives and emergencies potentially affecting supply chains and market volumes.